Clindamycin in the treatment of serious anaerobic infections.
D000038:Abscess / Q000188:drug therapy; D000197:Actinomycosis, Cervicofacial / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000693:Anaerobiosis; D001424:Bacterial Infections / Q000188:drug therapy*; D001442:Bacteroides Infections / Q000188:drug therapy; D001983:Bronchial Fistula / Q000188:drug therapy; D002481:Cellulitis / Q000188:drug therapy; D002981:Clindamycin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D004653:Empyema / Q000188:drug therapy; D005260:Female; D005402:Fistula / Q000188:drug therapy; D005673:Fusobacterium; D005738:Gas Gangrene / Q000188:drug therapy; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use*; D008169:Lung Abscess / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy; D010460:Peptococcus; D010995:Pleural Diseases / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D002981:Clindamycin; D008034:Lincomycin